Company Profile

With the declared objective of establishing integrated neurological imaging, mapping and therapy guidance portfolio, in June 2017 Royal Philips (NYSE: PHG, AEX: PHIA), announced an agreement to acquire Electrical Geodesics, Inc. (EGI). In an interesting follow-on to that transaction, it was announced in July 2020 that Transcranial magnetic stimulation tech developer Magstim had purchased the product portfolio of Electrical Geodesics from Royal Philips (NYSE:PHG). Extensively SBIR involved - 33 Phase I and 23 Phase II - EGI ia a US-based medical device company designing, developing and commercializing a range of non-invasive technologies used to monitor and interpret brain activity. The firm's portfolio of EEG hardware, software and acquisition sensors were discussed as complementing Philips’ existing portfolio of imaging technologies (e.g. MRI and PET-CT) and advanced informatics (e.g. IntelliSpace Portal) for neurological applications. The combined portfolios had been discussed as enabling Philips to address neurological disorders such as stroke, epilepsy, traumatic brain injury and Parkinson’s disease. EGI - Electrical Geodesics Inc - is a neurodiagnostic medical technology company developing a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity. In April 2013, the firm went public on London's AIM Exchange. EGI’s core technology, Geodesic EEG, provides non-invasive and high-resolution imaging of brain activity and is used to study a broad range of brain disorders, including epilepsy, autism, stroke, traumatic brain injury, and sleep disorders. EGI's new Geodesic Transcranial Electrical Neuromodulation (GTEN) technology was demonstrated at the Human Brain Mapping meeting in Honolulu. GTEN integrates EGI's core GES 400 dEEG platform and its proprietary head modeling algorithms to create a new technique for very precise neuromodulation. Released first for use in research, potential future medical applications for the new technology include epilepsy, depression, and tinnitus, among others.